New Section 232 tariffs impose up to 100% duties on patented drugs while offering relief tied to onshoring and MFN pricing commitments.
| less than a minute read
From Zero to 100% – New Section 232 Tariffs on Patented Drugs and the High-Stakes Onshoring and MFN Choices Ahead

/Passle/6880addbd954bf894713d5af/SearchServiceImages/2026-11-19-18-23-09-165-6aff3e8d1748b264d5a55940.jpg)
/Passle/6880addbd954bf894713d5af/SearchServiceImages/2026-11-19-18-25-24-196-6aff3f146841ccf0c13e1db2.jpg)

